The Association Between Biological Subtype and Isolated Regional Nodal Failure After Breast-Conserving Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 188-196

  Wo, Jennifer Y ^a   Taghian, Alphonse G ^b   Nguyen, Paul L ^a   Raad, Rita Abi ^b   Sreedhara, Meera ^a   Bellon, Jennifer R ^a   Wong, Julia S ^a   Gadd, Michele A ^b   Smith, Barbara L ^b   Harris, Jay R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biological subtype; Breast cancer; Regional nodal failure

Indexed keywords

BREAST CANCER; BREAST CONSERVING SURGERY; BREAST-CONSERVING THERAPY; ESTROGEN RECEPTOR; LOW RATES; LYMPH NODE; LYMPHOVASCULAR INVASIONS; PROGESTERONE RECEPTOR; RADIATION THERAPY; REGIONAL NODAL IRRADIATION; SENTINEL LYMPH NODES; SYSTEMIC THERAPY; TRASTUZUMAB; UNIVARIATE ANALYSIS;

BODY FLUIDS; MONOCLONAL ANTIBODIES; SURGERY;

RADIOTHERAPY;

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; ISOLATED REGIONAL NODAL FAILURE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; RISK; SENTINEL LYMPH NODE BIOPSY;

EID: 77950593219     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.059     Document Type: Article

References (38)

1. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355 (2000) 1757-1770
2. Ceilley E., Jagsi R., Goldberg S., et al. Radiotherapy for invasive breast cancer in North America and Europe: Results of a survey. Int J Radiat Oncol Biol Phys 61 (2005) 365-373
3. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
4. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
5. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
6. Galper M., Jensen M.B., Overgaard J., et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 45 (1999) 1157-1166
7. Recht A., Pierce S.M., Abner A., et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9 (1991) 988-996
8. Vicini F.A., Horwitz E.M., Lacerna M.D., et al. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 39 (1997) 1069-1076
9. Pejavar S., Wilson L.D., and Haffty B.G. Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). Int J Radiat Oncol Biol Phys 66 (2006) 1320-1327
10. Lingos T.I., Recht A., Vicini F., et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 21 (1991) 355-360
11. Coen J.J., Taghian A.G., Kachnic L.A., et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55 (2003) 1209-1215
12. Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23 (2005) 7475-7482
13. Olsen N.K., Pfeiffer P., Johannsen L., et al. Radiation-induced brachial plexopathy: Neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 26 (1993) 43-49
14. Kaufman E.L., Jacobson J.S., Hershman D.L., et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 26 (2008) 392-398
15. Virtanen A., Pukkala E., and Auvinen A. Angiosarcoma after radiotherapy: A cohort study of 332,163 Finnish cancer patients. Br J Cancer 97 (2007) 115-117
16. Information of EORTC protocols. Available from: URL: http://www.eortc.be/protoc/Details.asp?Protocol=22922. Date Accessed April 15, 2009.
17. Olivotto I.A., Chua B., Elliott E.A., et al. A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: The MA20 trial. Clin Breast Cancer 4 (2003) 361-363
18. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
19. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 (2001) 10869-10874
20. Sorlie T. Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities. Eur J Cancer 40 (2004) 2667-2675
21. Brenton J.D., Carey L.A., Ahmed A.A., et al. Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?. J Clin Oncol 23 (2005) 7350-7360
22. Sotiriou C., Neo S.Y., McShane L.M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 100 (2003) 10393-10398
23. Carey L.A., Perou C.M., Livasy C.A., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295 (2006) 2492-2502
24. Nguyen P.L., Taghian A.G., Katz M.S., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26 (2008) 2373-2378
25. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100 (2003) 8418-8423
26. Kyndi M., Sorensen F.B., Knudsen H., et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol 26 (2008) 1419-1426
27. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 (2005) 1659-1672
28. Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 (2005) 1673-1684
29. Haffty B.G., Yang Q., Reiss M., et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24 (2006) 5652-5657
30. Freedman G.M., Anderson P.R., Li T., et al. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 115 (2009) 946-951
31. Truong P.T., Jones S.O., Kader H.A., et al. Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 73 (2009) 357-364
32. Buchholz T.A., Tucker S.L., Erwin J., et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19 (2001) 2240-2246
33. Fisher B., Costantino J., Redmond C., et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320 (1989) 479-484
34. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
35. Harris E.E., Hwang W.T., Seyednejad F., et al. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer 98 (2003) 2144-2151
36. Webster L.R., Lee S.F., Ringland C., et al. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification. Clin Cancer Res 14 (2008) 6625-6633
37. Cheang M.C., Voduc D., Bajdik C., et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14 (2008) 1368-1376
38. Goss P.E., Ingle J.N., Martino S., et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349 (2003) 1793-1802